As the swine flu virus continues to spread many investors are buying into the biotech stock companies in hope of large gains. The best biotech stock will be the one that gets the approval as the first swine flu vaccine. So, which will be the best biotech stock?

Great investment opportunities lies around the corner, and the investment community knows that some will make it first and some won’t make it at all.

The Swine Flu Pandemic Crisis

Only equating a small portion of the UK healthcare industry in comparison to the US, the biotech companies showed an impressive return in April 2009 when the fear of a swine flu pandemic crisis flooded the media.

mt-swineflu_biotech2

A steep correction was imminent and it took place soon after, but you can already see that many held a solid 40% plus gain from the year-to-end. Those are the stocks to keep a close eye on.

The Importance of Cash Flow

They have carefully managed the cash flow when coping with the swine flu research expense, so there is longevity in many of them.

Biotech companies should have enough available funding to research for a swine flu vaccine, as well as guarantying production and distribution in large quantities. So, the stock picking won’t be easy if you don’t know what you are doing.

Steady Sales & Research Experience

Many pharmaceutical companies that are developing vaccines for the H1N1 Virus are already showing significant gains but primarily because they currently have products in the market and have proven experience on flu vaccine development. So, the increase on the share price has a clear solid foundation.

On the other hand, many companies with short term gains may experience heavy losses following vaccine failure. Results of prior tests gave investors a clear view that the stock picking won’t be an easy task if you are aiming for the short term gains.

Long Term Investment Strategy

In times of an economic crisis, gains can be made through smart analysis and intense research, and with the biotech stock companies, it is no different. The right stock pick will clearly be based on a long term approach rather than on a get-rich-quick-scheme.

A swine flu vaccine developed by any biotech companies will send their stocks soaring; you just have to look at their fundamentals, leave the gambling spirit on the side and focus on a long term investment strategy.

mt-swineflu_investmentprogram2